Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014:2014:238485.
doi: 10.1155/2014/238485. Epub 2014 Mar 9.

Role of methylglyoxal in Alzheimer's disease

Cristina Angeloni  1 , Laura Zambonin  2 , Silvana Hrelia  1
Affiliations
Review

Role of methylglyoxal in Alzheimer's disease

Cristina Angeloni et al. Biomed Res Int. 2014.

Abstract

Alzheimer's disease is the most common and lethal neurodegenerative disorder. The major hallmarks of Alzheimer's disease are extracellular aggregation of amyloid β peptides and, the presence of intracellular neurofibrillary tangles formed by precipitation/aggregation of hyperphosphorylated tau protein. The etiology of Alzheimer's disease is multifactorial and a full understanding of its pathogenesis remains elusive. Some years ago, it has been suggested that glycation may contribute to both extensive protein cross-linking and oxidative stress in Alzheimer's disease. Glycation is an endogenous process that leads to the production of a class of compounds known as advanced glycation end products (AGEs). Interestingly, increased levels of AGEs have been observed in brains of Alzheimer's disease patients. Methylglyoxal, a reactive intermediate of cellular metabolism, is the most potent precursor of AGEs and is strictly correlated with an increase of oxidative stress in Alzheimer's disease. Many studies are showing that methylglyoxal and methylglyoxal-derived AGEs play a key role in the etiopathogenesis of Alzheimer's disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Classical processes participating in the etiology and pathogenesis of AD (modified from [131]).
Figure 2
Figure 2
Role of MG and MG-derived AGEs in AD.
See this image and copyright information in PMC

References

    1. Zheng H, Koo EH. Biology and pathophysiology of the amyloid precursor protein. Molecular Neurodegeneration. 2011;6(1, article 27) - PMC - PubMed
    1. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-β oligomers: their production, toxicity and therapeutic inhibition. Biochemical Society Transactions. 2002;30(4):552–557. - PubMed
    1. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proceedings of the National Academy of Sciences of the United States of America. 1993;90(17):7951–7955. - PMC - PubMed
    1. Bulteau A-L, Verbeke P, Petropoulos I, Chaffotte A-F, Friguet B. Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. The Journal of Biological Chemistry. 2001;276(49):45662–45668. - PubMed
    1. Sachdev PS, Zhuang L, Braidy N, Wen W. Is Alzheimer's a disease of the white matter? Current Opinion in Psychiatry. 2013;26(3):244–251. - PubMed

Publication types

LinkOut - more resources